Browne L Daniel

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Revance Therapeutics Inc (RVNC)

Transaction date 18 Mar 2019

Planned sale

Price

485.83

Quantity 12,135 +1.5%

Value US$2,447,694

Comments Filing

Revance Therapeutics Inc (RVNC)

Transaction date 19 Feb 2019

Planned sale

Price

202.85

Quantity 29,067 -22.8%

Value US$1,828,010

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2019-03-19	2019-03-18	Revance Therapeutics Inc (RVNC)	PlS Planned sale	12,135 +1.5% 485.83 US$2,447,694	12,135 +1.5%	485.83	US$2,447,694
2019-02-20	2019-02-19	Revance Therapeutics Inc (RVNC)	PlS Planned sale	29,067 -22.8% 202.85 US$1,828,010	29,067 -22.8%	202.85	US$1,828,010